Sec. 103. PENALTIES

152 words·~1 min read·/statute-compilations/comps-10691/sec-103

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

## SEC. 103 PENALTIES ###

(a)Prohibited Acts Section 301 (21 U.S.C. 331) is amended by adding at the end the following: > > ###### “(ccc) > > > ######

(1)> > The resale of a compounded drug that is labeled ‘not for resale’ in accordance with section 503B. > > > #### “(2) > > With respect to a drug to be compounded pursuant to section 503A or 503B, the intentional falsification of a prescription, as applicable. > > > #### “(3) > > The failure to report drugs or adverse events by an entity that is registered in accordance with subsection

(b)of section 503B.” > . ###

(b)Misbranded Drugs Section 502 (21 U.S.C. 352) is amended by adding at the end the following: > > ###### “(bb) > > If the advertising or promotion of a compounded drug is false or misleading in any particular.” > .

Connectionstraces to 2

Traces to 2 documents

U.S. Code

Citation graph

cites case law

Sec. 103

PENALTIES

U.S.C.§ 331

U.S.C.§ 352

Cites 2Cited by 0 across 0 sources